InkVivo

This biotech company develops a proprietary polymer platform for the controlled and sustained release of active ingredients in oral and injectable drugs. Its technology, including the GARD and SHEALD platforms, is used to create gastroretentive and long-acting delivery systems for pharmaceutical and nutraceutical partners. The company is currently advancing therapeutic programs for iron deficiency anemia and neurodegenerative diseases such as Alzheimer's.